Not applicableLooking for participantsNCT04493723What this trial is testingSerial Tumour Biopsies and Blood Biomarkers in MelanomaWho this might be right forMelanoma The Christie NHS Foundation Trust 300
Not applicableActive Not RecruitingNCT07177638What this trial is testingA Community-based Educational Initiative to Raise Awareness of Melanoma and Other Skin Cancers.Who this might be right forSkin Cancer NYU Langone Health 45
Early research (Phase 1)Study completedNCT02166255What this trial is testingAPN401 in Treating Patients With Melanoma, Kidney Cancer, Pancreatic Cancer, or Other Solid Tumors That Are Metastatic or Cannot Be Removed By SurgeryWho this might be right forRecurrent MelanomaRecurrent Pancreatic CancerRecurrent Renal Cell Cancer+9 more Wake Forest University Health Sciences 17
Not applicableUnknownNCT05602337What this trial is testingA Prospective Multicenter Sample Collection Study Using Non-invasive Methods to Investigate Mutation Burden in Non-lesional Facial Skin of Patients With a Hx of Skin CancerWho this might be right forMelanoma and Other Malignant Neoplasms of Skin DermTech 180
Testing effectiveness (Phase 2)Study completedNCT02509598What this trial is testingLymphoseek® as a Lymphoid Tissue Targeting Agent in Pediatric Patients With Melanoma, Rhabdomyosarcoma, or Other Solid Tumors Who Are Undergoing Lymph Node MappingWho this might be right forRhabdomyosarcomaMelanoma Cardinal Health 414, LLC 24
Early research (Phase 1)Study completedNCT00498979What this trial is testingSodium Stibogluconate and IFNa-2b Followed By CDDP, VLB and DTIC Treating Pts.With Advanced Melanoma or Other CancersWho this might be right forStage IV Melanoma Case Comprehensive Cancer Center 22
Testing effectiveness (Phase 2)Study completedNCT04526899What this trial is testingInvestigate the Novel Agent BNT111 and Cemiplimab in Combination or as Single Agents in Patients With Advanced Melanoma That Has Not Responded to Other Forms of TreatmentWho this might be right forMelanoma Stage IIIMelanoma Stage IVUnresectable Melanoma BioNTech SE 184
Testing effectiveness (Phase 2)Study completedNCT03131908What this trial is testingStudy of the Selective PI3K-Beta Inhibitor GSK2636771 in Combination With Pembrolizumab in Patients With Metastatic Melanoma and PTEN LossWho this might be right forMelanoma and Other Malignant Neoplasms of SkinMetastatic Melanoma M.D. Anderson Cancer Center 28
Early research (Phase 1)Study completedNCT00002754What this trial is testingMonoclonal Antibody Therapy in Treating Patients With Primary or Metastatic Melanoma or Brain TumorsWho this might be right forBrain and Central Nervous System TumorsMelanoma (Skin)Metastatic Cancer Duke University 6
Early research (Phase 1)Ended earlyNCT07121829What this trial is testingTovorafenib (DAY101) or in Combination With Pimasertib for Participants With Melanoma and Other Solid TumorsWho this might be right forMelanomaSolid TumorPilocytic Astrocytoma+7 more Day One Biopharmaceuticals, Inc. 44
Testing effectiveness (Phase 2)Ended earlyNCT02554812What this trial is testingAvelumab In Combination With Other Cancer Immunotherapies In Advanced Malignancies (JAVELIN Medley)Who this might be right forAdvanced Cancer Pfizer 409
Testing effectiveness (Phase 2)Ended earlyNCT01586195What this trial is testingStudy Of Zelboraf (Vemurafenib) in Patients With Locally-Advanced, Unresectable, Stage IIIc Or Metastatic Melanoma and Activating Exon 15 BRAF Mutations Other Than V600EWho this might be right forMalignant Melanoma Genentech, Inc. 31
Early research (Phase 1)Ended earlyNCT03272464What this trial is testingINCB039110 in Combination With Dabrafenib and Trametinib in Patients With BRAF-mutant Melanoma and Other Solid Tumors.Who this might be right forMelanoma Massachusetts General Hospital 1
Early research (Phase 1)Study completedNCT02381314What this trial is testingSafety Study of Enoblituzumab (MGA271) in Combination With Ipilimumab in Refractory CancerWho this might be right forMelanomaNon Small Cell Lung Cancer MacroGenics 24
Testing effectiveness (Phase 2)Study completedNCT02816021What this trial is testingStudy of Oral Azacitidine (CC-486) in Combination With Pembrolizumab (MK-3475) in Patients With Metastatic MelanomaWho this might be right forMelanoma and Other Malignant Neoplasms of SkinMetastatic Melanoma M.D. Anderson Cancer Center 24
Testing effectiveness (Phase 2)Active Not RecruitingNCT04802876What this trial is testingEfficacy of Tislelizumab and Spartalizumab Across Multiple Cancer-types in Patients with PD1-high MRNA Expressing TumorsWho this might be right forMSI-H Colorectal CancerMelanomaAnal Carcinoma+28 more SOLTI Breast Cancer Research Group 184
Testing effectiveness (Phase 2)Active Not RecruitingNCT01989585What this trial is testingTesting the Addition of Navitoclax to the Combination of Dabrafenib and Trametinib in People Who Have BRAF Mutant MelanomaWho this might be right forClinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8Malignant Solid Neoplasm+2 more National Cancer Institute (NCI) 75
Early research (Phase 1)Ended earlyNCT04244552What this trial is testingA Phase 1b Trial of ATRC-101 in Adults With Advanced Solid MalignanciesWho this might be right forBreast CancerColorectal CancerOvarian Cancer+13 more Atreca, Inc. 87
Testing effectiveness (Phase 2)Study completedNCT04993677What this trial is testingSEA-CD40 Given With Other Drugs in CancersWho this might be right forMelanomaCarcinoma, Non-Small- Cell Lung Seagen Inc. 77
Early research (Phase 1)Active Not RecruitingNCT05907304What this trial is testingAssess Naporafenib (ERAS-254) Administered With Trametinib in Patients With RAS Q61X MutationsWho this might be right forAdvanced or Metastatic Solid Tumors Erasca, Inc. 86